“Because we are one NHS, our health system is uniquely placed to become the most advanced health system in the world – one where technology addresses the user need – making care better for patients, but just as importantly making life better for staff.” Mat Hancock, Secretary of State for Health July 2018“The Department of Health and Social Care believe the roll out of electronic prescribing systems across more hospitals could reduce errors by 50%.” BBC News 23 February 2018A recent study by university academics in Manchester, Sheffield and York and published by the Department of Health in February 2018 identified more than 230 million medication errors a year that took place in the NHS. On average, 712 deaths a year were definitively linked to adverse drug reactions being the main cause of death. The number of deaths where medication errors played a part ranged from anything between 1,700 to 22,303. The Medication errors: Short Life Working Group report makes recommendations for a programme of work to tackle medication error and improve medicine safety. The Working Group emphasis the “The accelerated roll-out and optimisation of hospital e-prescribing and medicines administration systems “ as a key priority. Matt Hancock, Secretary of State for Health has recently highlighted the importance of electronic prescribing systems, as state-of-the-art electronic systems which save money, give clinicians more time to spend on patients and reduce potentially deadly medication errors by up to 50% when compared to the old paper systems.“The benefits of Hospital E-prescribing and medicines administration (HePMA) are now well documented and demonstrate, amongst other things, a significant reduction in medication related error, particularly when systems have been optimised after implementation. Even without optimisation, a recent National Institute for Health Research (NIHR) funded study has shown that high-risk medication errors can be reduced by up to 50%, as well as showing the system to be cost effective. Optimisation however remains a challenge. It is clear from work undertaken by NIHR, and the national digital e-prescribing and medicines administration (HePMA) maturity information, that there are significant challenges and delays with sites optimising systems once they have been implemented. This is leading to delays in benefits being realised as expected, particularly around medication safety, and system generated errors being missed. HePMA systems are possibly one of the most challenging digital health systems to implement in provider organisations but the rewards more than outweigh this. Systems are technically complex. Successful implementation requires considerable change to working practices across three clinical professional groups (medicine, nursing and pharmacy). These challenges mean that implementing systems can take some time, typically 18 months to two years from conception to implementation. The rollout of HePMA systems across the NHS remains low – figures from November 2017 show that only 35% of acute Trusts had rolled out systems (where greater than 80% of inpatients prescriptions are written digitally) and less than 12% of mental health organisations…. In the context of robust evidence of clinical and cost effectiveness, the group considered that roll-out of HePMA must be accelerated.” The Report of the Short Life Working Group on reducing medication-related harm, Department of Health February 2018This National Summit will focus on the optimisation of Hospital Electronic Prescribing and Medicines Administration (HePMA) . The summit will examine the development of electronic prescribing systems towards advanced eprescribing and ensuring the full clinical benefits are achieved.Benefits of attending. This conference will enable you to:Network with colleagues who are working to optimise hospital electronic prescribing systemsUnderstand the national context including updates from the National Digital Exemplars ProgrammeDevelop your skills in enabling the clinical benefits of eprescribingLearn from established practice in the use of HePMA to change clinical behaviour and prescribing practicesUnderstand how to sustain and extend eprescribing into higher risk and complex areasLearn from case studies in paediatrics, critical care, mental health and paediatricsExplore the challenges in rolling out eprescribing trust wideDevelop your local strategy to eliminate medication errors associated with eprescribingSelf assess and reflect on your own practiceGain CPD accreditation points contributing to professional development and revalidation evidence